QuantGDI 50
1,284.30+6.92 +0.54%
QuantGDI 150
3,741.85+14.21 +0.38%
QuantGDI 450
9,103.60-15.48 -0.17%
QuantAIP 100
2,568.14+30.93 +1.22%
QuantAIP 200
4,812.77+42.66 +0.89%
QuantBIOT 100
1,937.52-8.37 -0.43%
QuantUV 100
3,318.47+21.06 +0.64%
QuantHM 50
2,884.12-11.73 -0.40%
QuantDIV 100
6,142.90+18.55 +0.30%
QuantGTH 100
4,027.61+33.24 +0.83%
QuantLEADER 100
1,842.19+9.47 +0.52%
NASDAQ 100
21,524.68+142.35 +0.67%
S&P 500
5,963.47+28.91 +0.49%

Research that grows with you, free to start

Start free with PIInneh’s core research, and upgrade when you want more charts, more history and more of PIInneh’s models.

Preview edition: plans open when live market data is connected. Prices are in US dollars.

ML/AI Price Projection Charting System

Each plan adds more charts, more history and more of the research. Every paid plan starts with a 14-day free trial.

Recommended

Investor

The core research and charts, with everyday limits.

$19.99$16.58/ month

billed monthlybilled yearly, $199

 Save $40.88 a year

Ask about early access
  • AI assistance
  • 1 watchlist alert
  • 4 charts per tab
  • 7 indicators per chart
  • 10 parallel chart connections
  • 10 years of financial history
  • 15 years of chart history
  • 20 price alerts
  • 20 technical alerts
  • 40 industry-relative financial ratios
  • 50 alerts
  • 50 company reports a month
  • 3 client-ready reports a month
  • π ratings for 50 companies
  • ML/AI price projection with 144 indicators and the 25 Factor Zoo factors, for the 500 largest companies
  • Order flow: Volume Profile
  • Custom timeframes
  • Custom range bars
  • Multiple watchlists
  • Price Replay
  • Paper Trading Lab
  • Exports to Excel and CSV
  • Indicators on indicators
  • Chart data export
  • Intraday charts
  • Multi-condition alerts
  • Volume candles
  • Fundamental analysis indicators
  • Superradiance trend
  • Insider Activist Divergence
  • Community: ideas, leaderboard and earnings rounds
  • Signals: after every close
  • Correlation tab
  • Financial estimates and projections tab
  • Intrinsic value and margin of safety tab
  • Biotech evaluation tab
  • First priority support
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access

Investor Plus

Adds the Correlation tab, more screens and more history.

$29.99$24.99/ month

billed monthlybilled yearly, $299.88

 Save $60 a year

Ask about early access
  • AI assistance
  • 3 watchlist alerts
  • 14 indicators per chart
  • 8 charts per tab
  • 20 parallel chart connections
  • 15 years of financial history
  • 20 years of chart history
  • 100 price alerts
  • 100 technical alerts
  • 70 industry-relative financial ratios
  • 150 alerts
  • 150 company reports a month
  • 10 client-ready reports a month
  • π ratings for 150 companies
  • ML/AI price projection with 144 indicators and the 25 Factor Zoo factors, for the 1,500 largest companies
  • Order flow: Volume Profile
  • Custom timeframes
  • Custom range bars
  • Multiple watchlists
  • Price Replay
  • Paper Trading Lab
  • Exports to Excel and CSV
  • Indicators on indicators
  • Chart data export
  • Intraday charts
  • Multi-condition alerts
  • Volume candles
  • Fundamental analysis indicators
  • Superradiance trend
  • Insider Activist Divergence
  • Community: ideas, leaderboard and earnings rounds
  • Signals: after every close
  • Correlation tab
  • Financial estimates and projections tab
  • Intrinsic value and margin of safety tab
  • Biotech evaluation tab
  • First priority support
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access

Investor Unlimited

Adds the financial estimates tab, full history and every company.

$39.99$33.25/ month

billed monthlybilled yearly, $399

 Save $80.88 a year

Ask about early access
  • AI assistance
  • 10 watchlist alerts
  • 25 indicators per chart
  • 16 charts per tab
  • 50 parallel chart connections
  • Full financial history
  • Full chart history
  • 400 price alerts
  • 400 technical alerts
  • 100 industry-relative financial ratios
  • 500 alerts
  • Unlimited company reports
  • 25 client-ready reports a month
  • π ratings for every covered company
  • ML/AI price projection with 144 indicators and the 25 Factor Zoo factors, for every covered company
  • Order flow: Volume Profile
  • Custom timeframes
  • Custom range bars
  • Multiple watchlists
  • Price Replay
  • Paper Trading Lab
  • Exports to Excel and CSV
  • Indicators on indicators
  • Chart data export
  • Intraday charts
  • Multi-condition alerts
  • Volume candles
  • Fundamental analysis indicators
  • Superradiance trend
  • Insider Activist Divergence
  • Community: ideas, leaderboard and earnings rounds
  • Signals: after every close
  • Correlation tab
  • Financial estimates and projections tab
  • Intrinsic value and margin of safety tab
  • Biotech evaluation tab
  • First priority support
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access

Pro seat

For professional use: advisers, analysts and teams.

$299$249.17/ month

billed monthlybilled yearly, $2,990

 Save $598 a year

Ask about early access
  • AI assistance
  • 15 watchlist alerts
  • 50 indicators per chart
  • 16 charts per tab
  • 200 parallel chart connections
  • Full financial history
  • Full chart history
  • 1,000 price alerts
  • 1,000 technical alerts
  • 100 industry-relative financial ratios
  • 500 alerts
  • Unlimited company reports
  • 50 client-ready reports a month
  • π ratings for every covered company
  • ML/AI price projection with 144 indicators and the 25 Factor Zoo factors, for every covered company
  • Order flow: Volume Profile
  • Custom timeframes
  • Custom range bars
  • Multiple watchlists
  • Price Replay
  • Paper Trading Lab
  • Exports to Excel and CSV
  • Indicators on indicators
  • Chart data export
  • Intraday charts
  • Multi-condition alerts
  • Volume candles
  • Fundamental analysis indicators
  • Superradiance trend
  • Insider Activist Divergence
  • Community: ideas, leaderboard and earnings rounds
  • Signals: after every close
  • Correlation tab
  • Financial estimates and projections tab
  • Intrinsic value and margin of safety tab
  • Biotech evaluation tab
  • First priority support
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access
Teams, firms and institutions

Several seats, an API licence, index licensing or a custom index: talk to us about the right plan.

See the business plans

Students and educators get 50% off Investor, Investor Plus and Investor Unlimited. Upgrade, downgrade or cancel at any time.

Financial Estimate & Projection Platform

Every forecast is shown as Lower | Central | Upper, with the reported results first and the forecast last.

Annual Estimates

The next fiscal year, line by line and segment by segment.

$9.99$8.25/ month

billed monthlybilled yearly, $99

 Save $20.88 a year

Ask about early access
  • Annual estimates
  • Revenue, net income, EPS, EBITDA and free cash flow for the next fiscal year, each given as Lower | Central | Upper
  • The last three reported years shown beside the estimate, with actuals first and the forecast last
  • Bankruptcy Risk for every year: Low, Medium or High
  • A Growth Score from 0 to 100 for every year
  • Industry averages for revenue, net income and EPS, for comparison
  • Annual segment estimates
  • A revenue estimate for each business segment, given as Lower | Central | Upper
  • Annual growth for each segment
  • Each segment’s share of revenue
  • Segment revenue history, year by year
  • Forecast drivers: what the estimate assumes
  • Quarterly estimates
  • Next-quarter revenue, net income, EPS, EBITDA and free cash flow, each given as Lower | Central | Upper
  • The last three reported quarters shown beside it
  • Bankruptcy Risk and Growth Score for every quarter
  • Quarterly industry averages
  • Quarterly segment estimates
  • A revenue estimate for each business segment, given as Lower | Central | Upper
  • Year-on-year and quarter-on-quarter growth for each segment
  • Each segment’s share of revenue
  • Segment revenue history, quarter by quarter
  • Forecast drivers: what the estimate assumes
  • Intrinsic value
  • Intrinsic value per share against the market price, charted over time
  • The upside gap: how far the price sits below or above intrinsic value
  • Ratings
  • Growth rating: Extremely Strong, Strong, Moderate, Weak or Poor
  • Valuation and risk grade: Deeply undervalued, Undervalued, Fairly valued, Overvalued, or Deeply overvalued or distressed
  • Research
  • Signals: after every close
  • Superradiance trend
  • 40 industry-relative financial ratios
  • 10 years of financial history
  • Insider Activist Divergence
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access

Annual + Quarterly

Adds the next quarter, with its own segment estimates.

$17.99$14.92/ month

billed monthlybilled yearly, $179

 Save $36.88 a year

Ask about early access
  • Annual estimates
  • Revenue, net income, EPS, EBITDA and free cash flow for the next fiscal year, each given as Lower | Central | Upper
  • The last three reported years shown beside the estimate, with actuals first and the forecast last
  • Bankruptcy Risk for every year: Low, Medium or High
  • A Growth Score from 0 to 100 for every year
  • Industry averages for revenue, net income and EPS, for comparison
  • Annual segment estimates
  • A revenue estimate for each business segment, given as Lower | Central | Upper
  • Annual growth for each segment
  • Each segment’s share of revenue
  • Segment revenue history, year by year
  • Forecast drivers: what the estimate assumes
  • Quarterly estimates
  • Next-quarter revenue, net income, EPS, EBITDA and free cash flow, each given as Lower | Central | Upper
  • The last three reported quarters shown beside it
  • Bankruptcy Risk and Growth Score for every quarter
  • Quarterly industry averages
  • Quarterly segment estimates
  • A revenue estimate for each business segment, given as Lower | Central | Upper
  • Year-on-year and quarter-on-quarter growth for each segment
  • Each segment’s share of revenue
  • Segment revenue history, quarter by quarter
  • Forecast drivers: what the estimate assumes
  • Intrinsic value
  • Intrinsic value per share against the market price, charted over time
  • The upside gap: how far the price sits below or above intrinsic value
  • Ratings
  • Growth rating: Extremely Strong, Strong, Moderate, Weak or Poor
  • Valuation and risk grade: Deeply undervalued, Undervalued, Fairly valued, Overvalued, or Deeply overvalued or distressed
  • Research
  • Signals: after every close
  • Superradiance trend
  • 70 industry-relative financial ratios
  • 15 years of financial history
  • Insider Activist Divergence
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access
Recommended

Estimates + Valuation

Adds intrinsic value and PIInneh’s growth and valuation ratings.

$29.99$24.92/ month

billed monthlybilled yearly, $299

 Save $60.88 a year

Ask about early access
  • Annual estimates
  • Revenue, net income, EPS, EBITDA and free cash flow for the next fiscal year, each given as Lower | Central | Upper
  • The last three reported years shown beside the estimate, with actuals first and the forecast last
  • Bankruptcy Risk for every year: Low, Medium or High
  • A Growth Score from 0 to 100 for every year
  • Industry averages for revenue, net income and EPS, for comparison
  • Annual segment estimates
  • A revenue estimate for each business segment, given as Lower | Central | Upper
  • Annual growth for each segment
  • Each segment’s share of revenue
  • Segment revenue history, year by year
  • Forecast drivers: what the estimate assumes
  • Quarterly estimates
  • Next-quarter revenue, net income, EPS, EBITDA and free cash flow, each given as Lower | Central | Upper
  • The last three reported quarters shown beside it
  • Bankruptcy Risk and Growth Score for every quarter
  • Quarterly industry averages
  • Quarterly segment estimates
  • A revenue estimate for each business segment, given as Lower | Central | Upper
  • Year-on-year and quarter-on-quarter growth for each segment
  • Each segment’s share of revenue
  • Segment revenue history, quarter by quarter
  • Forecast drivers: what the estimate assumes
  • Intrinsic value
  • Intrinsic value per share against the market price, charted over time
  • The upside gap: how far the price sits below or above intrinsic value
  • Ratings
  • Growth rating: Extremely Strong, Strong, Moderate, Weak or Poor
  • Valuation and risk grade: Deeply undervalued, Undervalued, Fairly valued, Overvalued, or Deeply overvalued or distressed
  • Research
  • Signals: after every close
  • Superradiance trend
  • 100 industry-relative financial ratios
  • Full financial history
  • Insider Activist Divergence
  • Screener
  • Quality at Fair Value
  • Deep Value (with a value-trap guard)
  • Distress Watch
  • Hedge Finder
  • Index Candidates
  • Results Table
  • Forensic Map
  • How Your Screen Narrowed (the funnel)
  • Why It Passed (the evidence for each company)
  • Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market Line
  • Portfolio Fit: hedges and diversifiers for your portfolio
  • Saved Screens & Alerts, rerun daily
  • Plain-Words Search: type what you want and it proposes the filters
  • Watch (adds a company to your Watchlist)
  • Export (CSV, Excel)
Ask about early access

Each box can be bought on its own, without a plan. Investor Unlimited includes Annual + Quarterly, and the Pro seat includes all three. Yearly billing is 12 months for the price of 10.
Not investment advice: the growth and valuation ratings are rules-based outputs of PIInneh’s models, not a recommendation to buy, sell or hold any security.

Indices, Correlation & Biotechnology Platforms

AI/ML-powered equity indices

The 11 PIInneh indices, with everything behind them.

$9.99$8.33/ month

billed monthlybilled yearly, $99.90

 Save $19.98 a year

Ask about early access
  • All 11 indices: constituents and weights, on screen for your own use (data files are licensed separately)
  • Reconstitutions
  • Weekly and daily diagnostics
  • Performance
  • Full index history, on screen
  • Black Swan Lab
Ask about early access

Correlation, diversification & hedging

Screen the whole market for the best hedges, and build maximum-diversification, tangency (maximum Sharpe) and minimum-variance portfolios.

$19.99$16.66/ month

billed monthlybilled yearly, $199.90

 Save $39.98 a year

Ask about early access
  • Matrix
  • Distribution
  • Market Link
  • Crisis Correlation
  • Distress Contagion
  • Forensic Map DDBio
  • Shock Simulator
  • Hidden Clusters
  • Why Correlated?
  • Stability & Breaks
  • Lead–Lag
  • Hedge & Diversify
  • Efficient Frontier
  • Forward ρ (ML)
  • Investor Brief
Ask about early access

Biotechnology intelligence & evaluation

Biotech companies valued program by program.

$24.99$20.83/ month

billed monthlybilled yearly, $249.90

 Save $49.98 a year

Ask about early access
  • Program-by-program value
  • Cash runway
  • Catalysts
  • Market target
  • Pipeline audit
  • Solvency
  • Scenario lab
  • Controls & audit
  • Commercial economics
  • Program detail
  • Revenue bridge
  • Value reconciliation
  • Evidence & coverage
  • Analysis
  • Superradiance trend
  • 100 industry-relative financial ratios
  • Bio financial projections
  • Insider Activist Divergence
Ask about early access

Each platform can be bought on its own, without a plan. Investor Plus and above include the Correlation tab, and the Pro seat the Biotech evaluation tab. Yearly billing is 12 months for the price of 10.

Investment Research Reports

Single report

One report, bought once. No subscription.

$5/ report

one-off payment

 

Ask about early access
  • Index factsheets
  • Research reports (whole market)
  • Signals report
  • Forensic ratings report
  • Black Swan report
  • Your reports
  • Decision report
  • Thesis report
  • Watchlist report
Ask about early access

Report top-up

25 extra reports for the rest of the month, for plan subscribers who run out.

$9.99/ 25 reports

one-off payment

 

Ask about early access
  • Index factsheets
  • Research reports (whole market)
  • Signals report
  • Forensic ratings report
  • Black Swan report
  • Your reports
  • Decision report
  • Thesis report
  • Watchlist report
Ask about early access

Client-ready reports

Unlimited reports carrying your own logo, ready to send to clients, for one adviser.

$99$82.50/ month per adviser

billed monthlybilled yearly, $990

 Save $198 a year

Ask about early access
  • Index factsheets
  • Research reports (whole market)
  • Signals report
  • Forensic ratings report
  • Black Swan report
  • Your reports
  • Decision report
  • Thesis report
  • Watchlist report
Ask about early access

A single report and a top-up are one-off payments; Monthly or Yearly applies to client-ready reports. Plans include 50 (Investor), 150 (Plus) or unlimited (Unlimited and Pro seat) company reports a month, and 3, 10, 25 or 50 client-ready reports a month; the client-ready box makes them unlimited for one adviser.

Compare plans

Every plan, side by side.

FeatureFreeGet early accessInvestorAsk about early accessInvestor PlusAsk about early accessInvestor UnlimitedAsk about early accessPro seatAsk about early access
Price
Monthly$0$19.99$29.99$39.99$299
Yearly (12 months for the price of 10)$0$199$299.88$399$2,990
Charts and alerts
Charts per tab1481616
Indicators per chart—7142550
Parallel chart connections—102050200
Watchlist alerts—131015
Price alerts—201004001,000
Technical alerts—201004001,000
Alerts—50150500500
Research
Financial history1 year10 years15 yearsFullFull
Chart history1 year15 years20 yearsFullFull
Industry-relative financial ratios54070100100
Company reports a monthNot included50150UnlimitedUnlimited
Client-ready reports a monthNot included3102550
π ratingsNot included50 companies150 companiesEvery covered companyEvery covered company
ML/AI price projection with 144 indicators and the 25 Factor Zoo factorsNot included500 largest1,500 largestEvery covered companyEvery covered company
SignalsOne day delayedAfter every closeAfter every closeAfter every closeAfter every close
Superradiance trendIncludedIncludedIncludedIncludedIncluded
Insider Activist DivergenceOne day delayedIncludedIncludedIncludedIncluded
Fundamental analysis indicatorsNot includedIncludedIncludedIncludedIncluded
Correlation tabNot includedNot includedIncludedIncludedIncluded
Financial estimates and projections tabNot includedNot includedNot includedIncludedIncluded
Intrinsic value and margin of safety tabNot includedNot includedNot includedNot includedIncluded
Biotech evaluation tabNot includedNot includedNot includedNot includedIncluded
Chart tools
AI assistanceNot includedIncludedIncludedIncludedIncluded
Order flow: Volume ProfileNot includedIncludedIncludedIncludedIncluded
Custom timeframesNot includedIncludedIncludedIncludedIncluded
Custom range barsNot includedIncludedIncludedIncludedIncluded
Multiple watchlistsNot includedIncludedIncludedIncludedIncluded
Price ReplayNot includedIncludedIncludedIncludedIncluded
Paper Trading LabIncludedIncludedIncludedIncludedIncluded
Exports to Excel and CSVNot includedIncludedIncludedIncludedIncluded
Indicators on indicatorsNot includedIncludedIncludedIncludedIncluded
Chart data exportNot includedIncludedIncludedIncludedIncluded
Intraday chartsNot includedIncludedIncludedIncludedIncluded
Multi-condition alertsNot includedIncludedIncludedIncludedIncluded
Volume candlesNot includedIncludedIncludedIncludedIncluded
Screener
Quality at Fair ValueNot includedNot includedNot includedNot includedIncluded
Deep Value (with a value-trap guard)Not includedNot includedNot includedNot includedIncluded
Distress WatchNot includedIncludedIncludedIncludedIncluded
Hedge FinderNot includedNot includedIncludedIncludedIncluded
Index CandidatesNot includedNot includedIncludedIncludedIncluded
Results TableNot includedIncludedIncludedIncludedIncluded
Forensic MapNot includedNot includedIncludedIncludedIncluded
How Your Screen Narrowed (the funnel)Not includedIncludedIncludedIncludedIncluded
Why It Passed (the evidence for each company)Not includedIncludedIncludedIncludedIncluded
Efficient Frontier: minimum variance, maximum Sharpe (tangency), Security Market LineNot includedNot includedNot includedIncludedIncluded
Portfolio Fit: hedges and diversifiers for your portfolioNot includedNot includedNot includedIncludedIncluded
Saved Screens & Alerts, rerun dailyNot includedNot includedIncludedIncludedIncluded
Plain-Words Search: type what you want and it proposes the filtersNot includedIncludedIncludedIncludedIncluded
Watch (adds a company to your Watchlist)Not includedIncludedIncludedIncludedIncluded
Export (CSV, Excel)Not includedIncludedIncludedIncludedIncluded
Support
First priority supportNot includedNot includedNot includedNot includedIncluded
Discounts
Student and educator discount—50% off50% off50% off—

Financial Ratios API

100 financial ratios, each measured against the company’s industry, with PIInneh’s π ratings, forecasts and intrinsic values. The API delivers PIInneh’s own data; stock prices are not included.

Developer

Personal use

$0free

500 calls a day · 1 year of ratio history · for testing

Get early access

Starter

Personal use

$49/ month

10,000 calls a day

Ask about early access

Pro

Personal use

$199/ month

100,000 calls a day · full ratio history · the AI-assistant connector

Ask about early access

Business

Internal use

$499/ month

Up to 5 users · 250,000 calls a day · full ratio history · the AI-assistant connector

Ask about early access

Display & Redistribution

Commercial use

From $1,499/ month

Show PIInneh’s ratios and ratings to your clients, or redistribute them; priced by audience size

Ask about early access

Personal plans are for your own use only. Extra calls on any paid plan: $10 per 1,000. The connector that lets your own AI assistant query PIInneh data is included in the API Pro and Business plans, or $99 a month per seat.

Add-ons

ItemWhat it isPrice
Forecast signals by API or webhookPIInneh’s forecasts sent to your own program (stock prices are not included)$99 a month (personal), from $1,500 a month (commercial)

Index licensing

For fund issuers, exchanges, banks and platforms using the 11 PIInneh indices. Most licences are charged on what is used: assets in the fund, contracts traded or notes outstanding, and index fund licences have no upfront fee and no minimum. Custom indices and the weighting-method licence carry the fees shown.

LicenceWho paysPrice
Index fund licenceA fund issuer tracking a PIInneh index and using its name8 bps on the first $1B of fund assets, 6 bps from $1B to $10B, 3 bps above $10B, a year; no flat fee, no minimum
Futures royaltyAn exchange listing futures on a PIInneh index$0.10 per standard contract, $0.02 per micro contract
Options royaltyAn exchange listing cash-settled options on a PIInneh index$0.10 per standard contract, $0.01 per one-tenth-size contract
Custom indexBanks, asset managers and wealth platforms$25,000 build and $15,000 a year per index, plus 4 bps if a product launches
Index from PIInneh research ranksFund issuersThe index fund licence rates above
Direct indexing and model portfoliosPlatforms whose accounts hold or copy the index3 bps of assets following the index, no minimum
Structured notes, insurance contracts and swapsBanks and insurers5 bps a year on notional outstanding
Weighting-method licenceIndex providers and asset managers using Active Floating Market Cap Weighted + 10% Cap2 bps of assets using the method, $50,000 yearly minimum

Each rate applies only to the assets in its band: a $50M fund pays $40,000 a year, a $1B fund $800,000, a $10B fund $6.2M and a $100B fund $33.2M. Fees accrue daily and are billed quarterly in arrears. Futures and options royalties are waived for the first 12 months or the first 1 million contracts, whichever comes first.

Index data

Index levels, the methodology and the top 10 holdings are free; index factsheets are reports (see Investment Research Reports). The files a professional needs are priced per index family, per year; there are eight families.

FileWhat it containsPrice per family
Public dataEnd-of-day index levels, methodology, top 10 holdingsFree
Index Membership fileThe full constituent list with identifiers, daily$3,000 a year
Index Weightings fileConstituent weights, share counts and the divisor, end-of-day and next-day (constituent prices are not included)$6,000 a year
Reconstitution and corporate-action noticesAdditions, deletions and weight changes before they take effect$12,000 a year
Index Weightings + NoticesBoth of the above together$15,000 a year
Back historyThe full history of index levels, weights and reconstitutions$5,000 one-off
All-families bundleWeightings and notices for all eight families$50,000 a year

Display to your own clients is 2× the list price and redistribution by a data vendor 3×; licensed fund issuers get the files for their index free.

Institutions and enterprise

For funds, banks, insurers, companies and universities. Prices scale with the client’s size.

LicenceWho it is forPrice
Point-in-time data feedSystematic funds: PIInneh’s ratios, ratings, forecasts and values, each stored as known on the day (stock prices are not included)$25,000 a year under $1B of fund assets, $60,000 from $1B to $10B, $120,000 above
Derived-works rightBuilding your own signals or products from the feed2× the feed price
Engine licencePIInneh’s models run inside your own systems$150,000 a year plus $50,000 setup
Paid pilotA 90-day institutional trial$25,000, credited against year one
Biotech valuationBiotech funds, pharma deal teams and bankers$30,000 a year for 3 seats, $6,000 per extra seat, $2,500 per single-asset report, $50,000 a year for the data feed
Corporate and investor relationsListed companies: their own company plus 10 peers$12,000 a year
Bankruptcy-risk scoresCredit, procurement and insurance teams$6,000 a year for 100 companies, $15,000 for 500, $30,000 for the full universe with API
Forensic accounting scoresInsurers, auditors and law firms$40,000 a year per firm
Broker and fintech embeddingPIInneh’s ratings shown inside your appPer monthly active user: $0.25 on the first 50,000, $0.10 on the next 450,000, $0.05 above; $2,500 monthly minimum
Rating display licenceA rated company or fund showing its PIInneh rating$5,000 a year under $2B market value, $10,000 from $2B to $10B, $25,000 above
Academic licenceUniversities, for research and teaching$5,000 a year per institution

Questions

When can I subscribe?

PIInneh is in its preview edition: plans open when live market data is connected. Ask for early access and we will tell you first.

What is the difference between the plans?

Each plan adds more. Charts, history, ratios, alerts and reports grow from plan to plan; the Correlation tab starts with Investor Plus, the financial estimates tab with Investor Unlimited, and the Pro seat adds the Intrinsic value and Biotech evaluation tabs, the full Screener and first priority support.

How does yearly billing work?

On yearly billing, Investor is $199 a year, Investor Plus $299.88, Investor Unlimited $399 and the Pro seat $2,990.

Is there a free trial?

Every paid plan starts with a 14-day free trial, and the Free plan stays free.

Is there a student discount?

Yes. Students and educators get 50% off Investor, Investor Plus and Investor Unlimited.

Can I change or cancel my plan?

Yes. You can upgrade, downgrade or cancel at any time.

Do the plans include stock prices?

The trading chart and reports show prices from PIInneh’s licensed data providers. PIInneh’s own data is its ratios, ratings, forecasts, intrinsic values and index calculations; the API, data feeds and licences deliver that data, not stock prices.

Can I use the API in my business?

Personal plans are for your own use. Using PIInneh data inside a firm needs the Business plan; showing it to clients or redistributing it needs Display & Redistribution.

What is a basis point?

One basis point (bp) is 0.01%. A fund with $1 billion in assets at 8 bps owes $800,000 a year, and the amount rises and falls with the fund’s assets.

Are these prices final?

Prices may change as market conditions and data costs change. The final terms of any licence are set out in the agreement signed with each client.

Start as
Preview edition: every figure is sample data until live market data is connected. See plans and pricing · What’s new